Open navigation

Grzegorz Dajer

Grzegorz Dajer is a director and co-founder of Medical Technology Transfer and Services (MTTS), an award-winning social enterprise, specializing in creating appropriate medical devices for neonatal intensive care. With a passion for innovation and problem-solving, Grzegorz has dedicated his career to pushing the boundaries of technology to create smarter, more efficient, and affordable systems.
Having Started his professional career in car industry, Grzegorz soon realized that his talent and passion can be used in more meaningful ways working with like-minded people on the other side of the world. He moved from Poland to Vietnam where he joined his wife with what turned out to be a life-long adventure in creating in impact in global public health.
Throughout his career, Grzegorz has worked on projects impacting millions of lives on all continents, ranging from equipping small clinics for Burmese refugees in Mae Sot to large national projects by USAID and UNICEF in Ghana and Ethiopia. His expertise lies in delivering the appropriate medical technologies to the one who need them, no matter how remote the location is.
Grzegorz's contributions to the field of social entrepreneurship were recognized by Shwab Foundation awarding him the title of the Social Entrepreneur of the year 2017. Together with his team at MTTS, he continues to create innovative solutions at a scale with the goal of achieving 10 million lives saved by the end of the decade.

For-profit Social Enterprise
Global Health
Viet Nam
Areas of Impact
ASEAN, South Asia, Middle East & North Africa, Latin America

Medical Technology and Transfer Service (MTTS)

Medical Technology and Transfer Service (MTTS) is a social enterprise that designs, manufactures and sells the LifeKit, a comprehensive suite of locally appropriate, high-quality medical devices to treat the most common causes of neonatal mortality and morbidity in low-resource countries. Some 75% of neonatal deaths are preventable through the LifeKit suite of products, which includes: Continuous Positive Airway Pressure (CPAP) machines for respiratory distress syndrome; radiant warmers for hypothermia; and phototherapy devices for jaundice. The LifeKit products are highly cost competitive. Compared to devices manufactured for more developed countries that are priced between $8,000 and $10,000, LifeKit products are sold for $1,000-$3,000.

To make products cost competitive while ensuring a long lifetime, MTTS uses materials easily sourced in the targeted low-resource countries. Furthermore, MTTS makes design choices that reduce the need for spare parts requiring periodic replacements, thereby eliminating recurring costs for hospitals. A key element of the LifeKit design philosophy is to identify and eliminate the most common sources of product failures in low-resource hospitals stemming from regular power fluctuations, lack of maintenance and inexperienced staff. For instance, Firefly, its phototherapy device, has eliminated typical internal moving parts, including fans and adjustable components that can be easily broken.

A key element of MTTS’s success is its three channels of distribution: commercial distribution through traditional sales channels and local distributors; contracts with government hospitals and international healthcare organizations; in select situations through MTTS's non-profit initiative, Day One, and other non-profit partners.

More than 750,000 babies have been treated directly with LifeKit devices and 1.3 million have benefited through the supportive services offered along with the devices. Over 3,000 devices have been installed in 390 hospitals across 35 countries worldwide. The MTTS Firefly, introduced to the market in 2014, has now become its flagship product, with over 900 units sold. In addition to focusing on Firefly's expansion, MTTS recently added its next generation Dolphin CPAP, Colibri Phototherapy and Wallaby Warmer machines to the LifeKit suite.


Our awardees